The medical technology business has been good for both companies, but which is right for your portfolio?
These stocks provide good yields and they don't come with much risk.
The big pharma company's top drug is losing ground, but its dividend keeps rising.
Discover 10 dividend growth powerhouses that could turbocharge your portfolio's long-term performance.
Discover the top three highest-rated, highest-yielding Dividend Aristocrats for your retirement portfolio.
ABT earnings call for the period ending June 30, 2024.
These stocks don't appeal only to dividend seekers.
September S&P 500 E-Mini futures (ESU24) are up +0.18%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.41% this morning, signaling a partial rebound from yesterday’s slump, while investors...
Johnson & Johnson (JNJ) beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer treatment Darzalex and blockbuster psoriasis drug Stelara....
September S&P 500 E-Mini futures (ESU24) are up +0.39%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.52% this morning as investors increased their bets on Donald Trump winning the U.S. presidential...